JW Therapeutics (čÆęå·ØčÆŗ) Pre-IPO: Pricing with In-License Potential
We provide a bottom-up rNPV based valuation for its key drugs, plus additional valuation for the potential in-licensing from Juno
563 Views
ECM Weekly (18 October 2020) - Lufax, Simcere, KWG Living, GDS, Jacobio
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This week...
559 Views
JW Therapeutics (čÆęå·ØčÆŗ) Pre-IPO: CAR-T Leader in China
JW Therapeutics is a leading China-based cell therapy company with the most advanced progress for the CAR-T commercialization. The company aims to...
930 Views